ImmunoGen announces webcast of speeches at the upcoming Jefferies Virtual Medical Conference

[ad_1]

ImmunoGen Inc. (Nasdaq:IMGN) Is a leader in the field of cancer drug therapy, today announced that Chief Financial Officer Susan Altschuller and Chief Medical Officer Anna Berkenblit will participate in the upcoming Fireside Chat Virtual Medical Conference at Jefferies. The speech is scheduled to be held at 9:30 am Eastern Time on June 2, 2021.

The webcast of the presentation can be accessed through the “Investors and Media” section of the company’s website: www.immunogen.com. After the live broadcast, it will be replayed at the same location.

About immunogens

ImmunoGen is developing next-generation antibody-drug conjugates (ADC) to improve the prognosis of cancer patients. By producing targeted therapies with enhanced anti-tumor activity and well-tolerated, we aim to disrupt the progression of cancer and provide our patients with a better life. We call it the promise of TARGET A BETTER NOW™.

Learn more about who we are, what we do and how we do it in the following locations. www.immunogen.com.

[ad_2]

Source link